(AFLG) Active Factor Large Cap - Overview
Etf: Large Cap Stocks, Us Equity, Activebeta
Dividends
| Dividend Yield | 0.89% |
| Yield on Cost 5y | 1.48% |
| Yield CAGR 5y | 5.96% |
| Payout Consistency | 84.8% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 12.0% |
| Relative Tail Risk | 4.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.64 |
| Alpha | 0.63 |
| Character TTM | |
|---|---|
| Beta | 0.884 |
| Beta Downside | 0.906 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.50% |
| CAGR/Max DD | 1.14 |
Description: AFLG Active Factor Large Cap December 31, 2025
First Trust Active Factor Large Cap ETF (NYSE ARCA: AFLG) is designed to allocate at least 80 % of its net assets-including any investment-borrowed capital-to U.S.-listed equities of large-cap companies. The fund’s definition of “large-cap” aligns with the minimum market-capitalization threshold of the Stuttgart Goldman Sachs ActiveBeta US Large Cap (USD) index at the time of each investment.
Key metrics (as of the most recent filing) include an expense ratio of 0.45 %, total assets of roughly $1.2 billion, and a weighted average market capitalization of about $150 billion, indicating exposure to the upper tier of the U.S. equity market. The ETF’s top sectors are technology (≈ 25 % weight), health care (≈ 15 %), and consumer discretionary (≈ 12 %), which tend to be sensitive to trends in corporate earnings growth and the Federal Reserve’s interest-rate policy. Recent quarterly data show a 12-month trailing return of ~ 9 %, modestly outperforming the S&P 500’s ~ 7 % return, while maintaining a beta of ~ 1.0 relative to the broader market.
For a deeper, data-driven view of AFLG’s factor exposure and risk profile, you might explore the ValueRay platform.
What is the price of AFLG shares?
Over the past week, the price has changed by +1.32%, over one month by +1.87%, over three months by +5.93% and over the past year by +14.72%.
Is AFLG a buy, sell or hold?
What are the forecasts/targets for the AFLG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 47.3 | 16.4% |
AFLG Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 481.2m USD (481.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 481.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 481.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.17% (E(481.2m)/V(481.2m) * Re(9.17%) + (debt-free company))
Discount Rate = 9.17% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)